|
P-230 Biomarkers associated with survival benefit to atezolizumab and bevacizumab for treatment of metastatic anal cancer |
|
|
|
Titel: |
P-230 Biomarkers associated with survival benefit to atezolizumab and bevacizumab for treatment of metastatic anal cancer |
Auteur: |
Morris, V. Zhu, H. Li, X. Johnson, B. Prasad, S. Mahvash, A. Sun, B. Gite, S. Panduregan, R. Parra, E. Knafl, M. Woodman, S. Eng, C. Halperin, D. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 34 () nr. S1 pagina's S97 |
Jaar: |
2023 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|